Discover 1,668 paid clinical trials in Durham, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,668
Active & Responsive
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: Raleigh NC, Towson MD, Stone Mountain GA,
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT07115329
Phase 2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Raleigh NC, Winston-Salem NC, Richmond VA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Raleigh NC, Rock Hill SC, Shelby NC, Virginia Beach VA,
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Cary NC, Huntersville NC, Columbia SC, Rockville MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Phase 4, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
for
Treatment-resistant Depression (TRD)
Location: Cary NC, Charlotte NC, Fairfax VA, Rockville MD,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70+
Code: NCT07553637
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
for
Diabetic Macular Edema (DME)
Location: Cary NC, Wake Forest NC, Greensboro NC,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT07734844
Phase 3, Recruiting
Active & Responsive
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
for
Schizophrenia
Location: Cary NC, Wilmington NC, Philadelphia PA, Atlanta GA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07379827
Recruiting
Active & Responsive
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
for
Major Depressive Disorder (MDD),
Location: Cary NC, North Canton OH, Brooklyn NY, Orlando FL,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07284667
Phase 2, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
for
Advanced Breast Cancer, Early Breast Cancer
Location: Cary NC, Washington D.C. DC, Athens GA, Savannah GA,
Sponsor: TerSera Therapeutics LLC
Sex: Female
Age: 18 - 55
Code: NCT07310420
Phase 1, Recruiting
Active & Responsive
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for
Metastatic Non-small Cell Lung Cancer
Location: Cary NC, Pittsburgh PA, Philadelphia PA,
Sponsor: NovoCure GmbH
Sex: All
Age: 18+
Code: NCT06216301
Phase 3, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Raleigh NC, Wilmington NC, Morehead City NC,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine